DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Found vs NexLife: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, month to month and all-in, Found charges $339 per 28-day cycle and NexLife $129 a month: $4,407 against $1,548 for a year, so NexLife costs $2,859 less over a year.

Released · Last reviewed · how we verify

On compounded semaglutide, month to month and all-in, Found charges $269 per 28-day cycle and NexLife $109 a month: $3,497 against $1,308 for a year, so NexLife costs $2,189 less over a year.

Found and NexLife, measure by measure

Found and NexLife side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureFoundNexLife
Tirzepatide, month to month$339 (per 28-day cycle)$129 (per month)
Tirzepatide, lowest printed$199 (12-month term, per 28-day cycle)$115 (12-month plan)
Semaglutide, month to month$269 (per 28-day cycle)$109 (per month)
Semaglutide, lowest printed$149 (12-month term, per 28-day cycle)$95 (12-month plan)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed score21 of 40 (position 12 of 27)33.6 of 40 (position 4 of 27)
FDA warning lettersnone listed730096 (2026-06-08)
November 20 readfirst-party read, changedfirst-party read

Strengths and limitations: which fits whom

Found bills every 28 days, which adds a 13th charge to the year. NexLife prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Foundtirzepatide—$339
Foundsemaglutide—$269

Regulatory record

FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Found’s current prices ↗

Frequently asked

Which is cheaper, Found or NexLife?

On compounded tirzepatide, month to month and all-in, Found charges $339 per 28-day cycle and NexLife $129 a month: $4,407 against $1,548 for a year, so NexLife costs $2,859 less over a year. On compounded semaglutide, month to month and all-in, Found charges $269 per 28-day cycle and NexLife $109 a month: $3,497 against $1,308 for a year, so NexLife costs $2,189 less over a year.

Do Found and NexLife charge a membership fee?

Found: no membership fee; NexLife: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Found and NexLife medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Found recordFound alternativesNexLife recordNexLife alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.